JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paul, M.
Right arrow Articles by Yost, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paul, M.
Right arrow Articles by Yost, C. S.
Related Collections
Right arrow Pharmacology
Anesth Analg 2002;94:597-603
© 2002 International Anesthesia Research Society


ANESTHETIC PHARMACOLOGY

The Potency of New Muscle Relaxants on Recombinant Muscle-Type Acetylcholine Receptors

Matthias Paul, MD DEAA*, Christoph H. Kindler, MD DEAA{dagger}, Ralf M. Fokt*, Mark J. Dresser, PhD{ddagger}, Natalie C. J. Dipp§, and C. Spencer Yost, MD*

*Department of Anesthesia and Perioperative Care, University of California, San Francisco; {dagger}Department of Anesthesia, Kantonsspital, Basel, Switzerland; {ddagger}Department of Biopharmaceutical Sciences, University of California, San Francisco; and §Department of Anesthesia, University of Cologne, Germany

Address correspondence and reprint requests to C. Spencer Yost, MD, Department of Anesthesia and Perioperative Care, University of California, 513 Parnassus Ave., Box 0542, San Francisco, CA 94143-0542. Address e-mail to spyost{at}itsa.ucsf.edu

We studied the inhibition of fetal ({gamma}-nAChR) and adult ({epsilon}-nAChR) muscle-type nicotinic acetylcholine receptors by the two new nondepolarizing muscle relaxants (NDMRs) rocuronium and rapacuronium, the metabolite 3-desacetyl rapacuronium (Org 9488), and five other, longer-used NDMRs (pancuronium, vecuronium, mivacurium, d-tubocurarine, and gallamine). Receptors were expressed in Xenopus laevis oocytes by cytoplasmic injection of subunit complementary RNAs. Functional channels were activated with 10 µM acetylcholine, alone or in combination with various concentrations of the NDMRs. Currents were recorded with a whole-cell two-electrode voltage clamp technique. All NDMRs reversibly inhibited acetylcholine-activated currents in a dose-dependent fashion. Potencies of rapacuronium and Org 9488 were not statistically different at either {gamma}-nAChR (half-maximal response = 58.2 and 36.5 nM, respectively) or {epsilon}-nAChR (half-maximal response = 80.3 and 97.7 nM, respectively). The rank order of potencies at the {epsilon}-nAChR (pancuronium > vecuronium ~ mivacurium > rocuronium ~ d-tubocurarine > rapacuronium ~ Org 9488 > gallamine) correlated highly with the clinical doses needed to produce 50% twitch depression at the adductor pollicis muscle in adults. Neuromuscular blockade by rapacuronium may be enhanced by its metabolite Org 9488. Different drug-receptor affinities of the tested NDMRs contribute to the differences in clinical dose requirements of these drugs needed to achieve appropriate muscle relaxation.

IMPLICATIONS: Potencies of nondepolarizing muscle relaxants, studied at muscle nicotinic acetylcholine receptors expressed in a recombinant expression system, correlate highly with the clinical doses needed in adults to produce 50% twitch depression at the adductor pollicis muscle.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
M. Paul, R. Callahan, J. Au, C. H. Kindler, and C. S. Yost
Antiemetics of the 5-Hydroxytryptamine 3A Antagonist Class Inhibit Muscle Nicotinic Acetylcholine Receptors
Anesth. Analg., September 1, 2005; 101(3): 715 - 721.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
V. Nigrovic, M. Paul, C. H. Kindler, and C. S. Yost
The Potency of New Muscle Relaxants on Recombinant Muscle-Type Acetylcholine Receptors * Response
Anesth. Analg., November 1, 2002; 95(5): 1459 - 1459.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. Paul, R. M. Fokt, C. H. Kindler, N. C. J. Dipp, and C. S. Yost
Characterization of the Interactions Between Volatile Anesthetics and Neuromuscular Blockers at the Muscle Nicotinic Acetylcholine Receptor
Anesth. Analg., August 1, 2002; 95(2): 362 - 367.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2002 by the International Anesthesia Research Society.